Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004914 · ClinicalTrials.gov registry record · Phase 2
Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00004914 is a Phase 2 study that has completed, run by Northwestern University.
The verdict
NCT00004914, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Exercise may decrease anemia-related fatigue, improve strength, and build up lost muscle tissue. Epoetin alfa may help improve cancer-related anemia, energy levels, and quality of life. Exercise plus epoetin alfa may be effective treatment for anemia-related fatigue. PURPOSE: Phase II trial to study the effectiveness of exercise plus epoetin alfa in treating cancer patients who have anemia-related fatigue.
Interventions
- BIOLOGICAL epoetin alfa
- PROCEDURE physical therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-01 |
| Est. Completion | 2001-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004914
The ClinicalTrials.gov registry entry for NCT00004914 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which epoetin alfa is the first listed.
NCT00004914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004914 about?
NCT00004914 is a clinical study titled "Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue". RATIONALE: Exercise may decrease anemia-related fatigue, improve strength, and build up lost muscle tissue. Epoetin alfa may help improve cancer-related anemia, energy levels, and quality of life. Exercise plus epoetin alfa may be effective treatment for anemia-related fatigue. PURPOSE: Phase II tr...
What is the current status of trial NCT00004914?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-01. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00004914?
The interventions under investigation include: epoetin alfa (BIOLOGICAL), physical therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00004914?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.